AR059054A1 - Variante d3n de glicosilacion fsh novedosa - Google Patents

Variante d3n de glicosilacion fsh novedosa

Info

Publication number
AR059054A1
AR059054A1 ARP070100200A ARP070100200A AR059054A1 AR 059054 A1 AR059054 A1 AR 059054A1 AR P070100200 A ARP070100200 A AR P070100200A AR P070100200 A ARP070100200 A AR P070100200A AR 059054 A1 AR059054 A1 AR 059054A1
Authority
AR
Argentina
Prior art keywords
novedosa
glycosilation
variante
fsh mutant
folliclegenesis
Prior art date
Application number
ARP070100200A
Other languages
English (en)
Original Assignee
Serono Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Lab filed Critical Serono Lab
Publication of AR059054A1 publication Critical patent/AR059054A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Physics & Mathematics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se describe el mutante de la FSH con glicosilacion aumentada y vida media más larga. También se describe el uso de este mutante de la FSH para inducir la folículo-génesis en pacientes humanos.
ARP070100200A 2006-01-17 2007-01-17 Variante d3n de glicosilacion fsh novedosa AR059054A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75948606P 2006-01-17 2006-01-17

Publications (1)

Publication Number Publication Date
AR059054A1 true AR059054A1 (es) 2008-03-12

Family

ID=38163618

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070100200A AR059054A1 (es) 2006-01-17 2007-01-17 Variante d3n de glicosilacion fsh novedosa

Country Status (22)

Country Link
US (1) US7956034B2 (es)
EP (1) EP1981908B1 (es)
JP (1) JP2009523445A (es)
KR (1) KR20080094697A (es)
CN (1) CN101370825B (es)
AR (1) AR059054A1 (es)
AT (1) ATE487738T1 (es)
AU (1) AU2007207697B2 (es)
BR (1) BRPI0706628A2 (es)
CA (1) CA2633844A1 (es)
CY (1) CY1110953T1 (es)
DE (1) DE602007010425D1 (es)
DK (1) DK1981908T3 (es)
EA (1) EA013974B1 (es)
HR (1) HRP20100610T1 (es)
IL (1) IL192547A (es)
PL (1) PL1981908T3 (es)
PT (1) PT1981908E (es)
RS (1) RS51792B (es)
SI (1) SI1981908T1 (es)
WO (1) WO2007084441A2 (es)
ZA (1) ZA200805194B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA015901B1 (ru) 2005-08-26 2011-12-30 Арес Трейдинг С.А. Способ получения гликозилированного интерферона бета
US8604175B2 (en) * 2005-12-09 2013-12-10 Ares Trading S.A. Method for purifying FSH or a FSH mutant
JP5249044B2 (ja) 2005-12-22 2013-07-31 メルク セローノ ソシエテ アノニム Ｆｓｈ突然変異体
JP2011500757A (ja) * 2007-10-22 2011-01-06 メルク セローノ ソシエテ アノニム Ｆｃ含有タンパク質の精製方法
EP2203474A1 (en) * 2007-10-22 2010-07-07 Merck Serono S.A. Method for purifying fc-fusion proteins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3950484B2 (ja) * 1997-06-25 2007-08-01 アプライド・リサーチ・システムズ・エイアールエス・ホールディング・ナムローゼ・フェンノートシャップ ジスルフィド架橋結合した糖タンパク質ホルモン類似体類およびそれらの調製および使用
WO2001058493A1 (en) * 2000-02-11 2001-08-16 Maxygen Aps Conjugates of follicle stimulating hormones
IL161541A0 (en) * 2001-10-22 2004-09-27 Applied Research Systems Mutant glycoproteins
UA88879C2 (en) * 2003-09-02 2009-12-10 Эплайд Рисерч Системз Эрс Холдинг Н.В. Fsh glycosylation mutant
US8604175B2 (en) * 2005-12-09 2013-12-10 Ares Trading S.A. Method for purifying FSH or a FSH mutant

Also Published As

Publication number Publication date
EA200870177A1 (ru) 2009-02-27
RS51792B (en) 2011-12-31
EP1981908A2 (en) 2008-10-22
PT1981908E (pt) 2010-11-23
CN101370825A (zh) 2009-02-18
PL1981908T3 (pl) 2011-04-29
CN101370825B (zh) 2012-10-10
ATE487738T1 (de) 2010-11-15
SI1981908T1 (sl) 2011-01-31
AU2007207697A1 (en) 2007-07-26
WO2007084441A2 (en) 2007-07-26
WO2007084441A3 (en) 2007-09-07
EP1981908B1 (en) 2010-11-10
ZA200805194B (en) 2009-10-28
BRPI0706628A2 (pt) 2011-04-05
US20080280832A1 (en) 2008-11-13
EA013974B1 (ru) 2010-08-30
IL192547A0 (en) 2009-02-11
JP2009523445A (ja) 2009-06-25
KR20080094697A (ko) 2008-10-23
IL192547A (en) 2012-04-30
DK1981908T3 (da) 2010-12-13
AU2007207697B2 (en) 2012-01-19
AU2007207697A2 (en) 2008-07-31
DE602007010425D1 (de) 2010-12-23
US7956034B2 (en) 2011-06-07
CY1110953T1 (el) 2015-06-11
HRP20100610T1 (hr) 2010-12-31
CA2633844A1 (en) 2007-07-26

Similar Documents

Publication Publication Date Title
UA94221C2 (en) Lipocalin protein
AU314936S (en) Remote control
ATE535603T1 (de) Mutante reverse transkriptase und verwendungsverfahren
MX2007011493A (es) Modalidades antiinflamatorias.
AR059054A1 (es) Variante d3n de glicosilacion fsh novedosa
HRP20090513T1 (en) S-mirtazapine for the treatment of hot flush
CA118372S (en) Trapeze hanger
ECSP12011893A (es) Combinación de fármacos con teobromina y su uso en terapia
AU313307S (en) Bowl
ECSP088646A (es) Mutantes de fsh.
AU311982S (en) Chair
AU312245S (en) Writing instrument
AU305339S (en) Fountain
AU309534S (en) Work lamp
AU302388S (en) Screws
TR200602806U (tr) Mobilya ayaklarında kullanılan gövde ile tabanı bağlantı sistemi.
AU305665S (en) Desk screen and desk (single unit)
AU305664S (en) Desk screen
AU314602S (en) Armrest
AU308285S (en) Navigation system
AU308000S (en) Navigation system
UA29769U (ru) Применение мигрепина как вещества с противовоспалительными и жаропонижающими свойствами
AU317029S (en) Lighting unit
CA110807S (en) Notebook
AU302725S (en) Fountain

Legal Events

Date Code Title Description
FA Abandonment or withdrawal